Table 1

Clinical details of patients

PatientAge and sex (y)Duration of Parkinsons’s disease (y)Hoehn and Yahr stage1-150More severe sideUPDRS motor score
Off/On
Levodopa taken during study (mg)1-151Total daily dose levodopa of (mg)2Other medications
157 M1IL6/1250500Pergolide
270 M4IIR10/5250500None
374 M5IIL8/2250500None
458 M12IIR13/92501125Tolcapone
571 F14IIIR30/11250750None
646 M15IIIR24/6250750Pergolide, Selegiline
780 F3.5IIIR15/9250625None
853 F6.5IIL10/5200700None
964 M3IIIR19/12125375None
1051 M8.5IIL13/33751125None
  • 1-150 Off medication.

  • 1-151 With peripheral decarboxylase inhibitor.